ADGRG3 and experimental autoimmune encephalomyelitis: The Gpr97-deficient mice were subsequently tested in various experimental disease models, revealing a role for Gpr97 in promoting obesity-associated macrophage inflammation, aggravating acute kidney injury (AKI), and reducing the severity of experimental autoimmune encephalomyelitis (EAE) [148,149,150].